Cardinal Health Q4 2024 Adj. EPS $1.84 Beats $1.73 Estimate, Sales $59.867B Beat $58.636B Estimate
Portfolio Pulse from Benzinga Newsdesk
Cardinal Health reported its Q4 2024 results, with adjusted EPS of $1.84 beating the estimate of $1.73, and sales of $59.867 billion surpassing the expected $58.636 billion.
August 14, 2024 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardinal Health's Q4 2024 earnings report shows strong performance with adjusted EPS of $1.84 beating estimates and sales of $59.867 billion exceeding expectations.
Cardinal Health's better-than-expected earnings and sales figures indicate strong financial health and operational efficiency, likely boosting investor confidence and driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100